News

Zacks Investment Research on MSN22h
Acquisitions, Licensing Deals Take Centerstage in Pharma/Biotech Space
Mergers and Acquisitions (M&A) have picked up significant pace in 2025 in the pharma/biotech sector after a passive run in 2024. The recent spree of acquisitions signifies a focus on portfolio ...
Neurofibromatosis Type 1 (NF1) Drug Development Gains Momentum Amid Growing Need For Safer, More Effective Therapies
DataM Intelligence | competitive Intelligence NF1 drug development accelerates with novel treatments aiming to surpass current MEK inhibito ...